A protein called angiopoietin-2 (ANGPT2) can both inhibit and encourage blood vessel changes critical for sepsis, a leading ...

SEP-1 was adopted based on evidence that bundle compliance was associated with lower mortality rates. In 2023, CMS announced ...

Sepsis, a life-threatening condition caused by the body's dysregulated response to infection, remains a leading cause of ...

Sepsis kills more people than breast (11,400), bowel (16,300) and prostate cancer (11,700) combined (39,400) in the UK Dr Helen adds: “Early recognition and management is key to survival.

They assess recent human studies bolstering the notion that immunosuppression is also a major contributor to the disease. Many people with sepsis succumb to cardiac dysfunction, a process examined ...

Sobi® (STO: SOBI), today announced a research collaboration involving a new Phase 2a clinical trial for Gamifant® (emapalumab) for the potential treatment of interferon-gamma (IFNγ)-driven sepsis (IDS ...

A new interactive tool from AHRQ allows researchers, policymakers and others to explore trends in hospital care for sepsis, a life-threatening condition that is among the most expensive to treat in U.

Covert, 19, never thought she could face the same fate. She got her flu shot yearly without question. But last ...

A new study raises critical questions about the effectiveness of the Centers for Medicare and Medicaid Services' (CMS) sepsis quality measure, known as the Severe Sepsis/Septic Shock Management Bundle ...

Along with sepsis and cardiac complications like myocarditis ... from celebrity news to compelling human interest stories.

Sobi® (STO: SOBI), today announced a research collaboration involving a new Phase 2a clinical trial for Gamifant® (emapalumab) for the potential treatment of interferon-gamma (IFNγ)-driven sepsis (IDS ...

Sobi announces a new research collaboration on the development of Gamifant in sepsis, which is to be presented at the ISICEM congress: Stockholm Thursday, March 20, 2025, 12:00 Hr ...